HSV 檢測市場：按 HSV 類型、檢體類型、年齡層、應用、最終用戶和地區分類

2025 年 HSV 檢測市場價值估計為 6.424 億美元，預計到 2032 年將達到 9.723 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 6.1%。

全球HSV檢測市場是診斷檢測產業的重要組成部分，專注於檢測和鑑定影響全球數百萬人的單純皰疹病毒感染。 HSV檢測涵蓋多種診斷方法，包括基於PCR的檢測、抗原檢測、基於抗體的血清學檢測和病毒培養技術，每種方法都旨在識別HSV-1和HSV-2感染，其靈敏度和特異性各不相同。

由於人們對性行為感染認知的不斷提高、全球皰疹感染疾病的盛行率不斷上升以及對早期診斷和治療性介入的日益重視，市場的重要性正在顯著擴大。醫療保健提供者、臨床實驗室和就地檢驗機構構成了推動 HSV 檢測解決方案需求的主要最終用戶。市場格局的特點是技術的不斷進步，例如快速診斷測試、準確性更高的分子診斷以及可提高工作流程效率的自動化測試平台的開發。此外，數位健康解決方案和遠端醫療平台的整合為提高 HSV 檢測的可近性創造了新途徑，特別是在偏遠和服務不足的地區。市場發展受到監管機構對新檢測方法的核准、醫療保健支出的增加以及患者對保密和便捷檢測方式的偏好日益增加的影響。

市場動態

全球HSV檢測市場受多種關鍵促進因素驅動，這些因素正在加速市場擴張，並促進各醫療機構的採用率。其中，最關鍵的促進因素是全球單純皰疹病毒感染疾病的日益普及。世界衛生組織估計，全球50歲以下人口中超過37億人感染疾病HSV-1，15-49歲人群中4.91億人感染疾病HSV-2，這導致對精準診斷解決方案的需求龐大。

分子診斷技術進步，尤其是即時PCR和次世代定序技術，一直是關鍵的成長驅動力，與傳統檢測方法相比，這些技術具有更高的靈敏度、特異性和快速的周轉時間。性行為感染傳染病宣導活動的不斷加強以及人們對預防保健日益成長的興趣，進一步刺激了市場需求。然而，市場也面臨著許多限制因素，例如先進分子診斷設備和檢測程序的高昂成本，限制了它們在資源匱乏的醫療機構中的普及。此外，與單純皰疹病毒（HSV）檢測相關的社會污名化也構成了心理障礙，可能會阻礙人們尋求診斷服務，從而限制市場成長。監管的複雜性和新診斷方法的核准時間緩慢也給尋求創新解決方案的市場相關人員帶來了挑戰。儘管存在這些限制因素，但隨著就地檢驗能力的提升、私密性和便捷性兼具的家用檢測套組的日益普及，以及醫療基礎設施日益完善的新興市場的日益普及，巨大的商機正在機會。人工智慧和機器學習在診斷平台中的整合為提高準確性和自動解釋結果提供了機會，而診斷公司和遠端醫療平台之間的合作則創造了新的分銷管道，並改善了服務不足人群的檢測機會。

本次調查的主要特點

• 本報告對全球 HSV 檢測市場進行了詳細分析，並提供了預測期（2025-2032 年）的市場規模和年複合成長率（CAGR%），以 2024 年為基準年。
• 它還強調了各個領域的潛在商機，並說明了該市場有吸引力的投資提案矩陣。
• 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的主要考察。
• 它根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數概述了全球 HSV 測試市場的主要企業。
• 本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
• 全球 HSV 測試市場報告涉及該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
• 相關人員可以透過全球 HSV 測試市場分析中使用的各種策略矩陣更輕鬆地做出決策。

目錄

第1章：調查目標和先決條件

• 調查目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告描述
  • 市場定義和範圍
• 執行摘要

第3章：市場動態、法規與趨勢分析

• 市場動態
• 驅動程式
• 抑制因素
• 機會
• 影響分析
• 監管情景
• 產品發布/核准
• PEST分析
• 波特分析
• 併購場景
• 產業趨勢

4. 2020-2032 年全球 HSV 檢測市場（按 HSV 類型分類）（百萬美元）

• 介紹
• HSV-2檢測
• HSV-1檢測
• HSV類型未指定/組合測試

5.全球HSV 檢測市場（按類型），2020 年至 2032 年

• 介紹
• 直接檢測或培養測試（病毒培養）
• 分子檢測（PCR、TMA、NAAT等）
• 血清學檢測（如抗體檢測）
• 快速抗原檢測（層析法）
• 其他（產前篩檢小組、居家採集套件包等）

6.全球HSV 檢測市場（依樣本類型），2020-2032 年

• 介紹
• 血液/血清/血漿
• 水痘拭子/體液
• 潰瘍/焦痂拭子
• 腦脊髓液（CSF）
• 其他體液（如支氣管肺泡灌洗液）

7. 2020-2032 年全球 HSV 檢測市場（按年齡層別分類）

• 介紹
• 嬰兒和新生兒
• 嬰兒
• 成人
• 老年人

8.全球HSV 檢測市場（按應用分類），2020 年至 2032 年

• 介紹
• 臨床疾病診斷
• 流行病學研究（篩檢）
• 監控與監測
• 其他

9.全球HSV 檢測市場（按最終用戶分類），2020 年至 2032 年

• 介紹
• 醫院
• 臨床診斷實驗室
• 居家照護
• 照護現場環境
• 血庫和血漿採集中心
• 其他（研究和學術機構）

10. 2020 年至 2032 年全球 HSV 檢測市場（按地區分類）價值

• 介紹
• 北美洲
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
• 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 東南亞國協
  • 其他亞太地區
• 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東地區
• 非洲
  • 南非
  • 北非
  • 中部非洲

第11章競爭格局

• Roche Diagnostics
• Abbott Laboratories
• Siemens Healthineers
• BioMerieux
• Thermo Fisher Scientific
• Hologic Inc.
• BD（Becton Dickinson）
• Cepheid
• Quidel Corporation
• DiaSorin
• PerkinElmer
• Beckman Coulter
• Agilent Technologies
• Sysmex Corporation
• Ortho Clinical Diagnostics

第 12 章分析師建議

• 機會
• 一致的機會地圖

第13章參考文獻與調查方法

• 參考
• 調查方法
• 關於出版商

HSV Testing Market is estimated to be valued at USD 642.4 Mn in 2025 and is expected to reach USD 972.3 Mn by 2032, growing at a compound annual growth rate (CAGR) of 6.1% from 2025 to 2032.

The global HSV testing market represents a critical segment within the broader diagnostic testing industry, focusing on the detection and identification of Herpes Simplex Virus infections that affect millions of individuals worldwide. HSV testing encompasses various diagnostic methodologies including PCR-based assays, antigen detection tests, antibody-based serological tests, and viral culture techniques, each designed to identify HSV-1 and HSV-2 infections with varying degrees of sensitivity and specificity.

The market's significance has grown substantially, due to increasing awareness about sexually transmitted infections, rising prevalence of herpes infections globally, and the growing emphasis on early diagnosis and treatment intervention. Healthcare providers, clinical laboratories, and point-of-care testing facilities constitute the primary end-users driving demand for HSV testing solutions. The market landscape is characterized by continuous technological advancements, including the development of rapid diagnostic tests, molecular diagnostics with enhanced accuracy, and automated testing platforms that improve workflow efficiency. Additionally, the integration of digital health solutions and telemedicine platforms has created new avenues for HSV testing accessibility, particularly in remote and underserved regions. The market's evolution is further influenced by regulatory approvals for novel testing methodologies, increasing healthcare expenditure, and growing patient preference for confidential and convenient testing options.

Market Dynamics

The global HSV testing market is propelled by several key drivers that collectively enhance market expansion and adoption rates across diverse healthcare settings. The primary driver stems from the escalating global prevalence of herpes simplex virus infections, with WHO estimates indicating that over 3.7 billion people under age 50 have HSV-1 infection and 491 million people aged 15-49 have HSV-2 infection worldwide, creating substantial demand for accurate diagnostic solutions.

Technological advancements in molecular diagnostics, particularly real-time PCR and next-generation sequencing techniques, serve as significant growth catalysts by offering superior sensitivity, specificity, and rapid turnaround times compared to traditional testing methods. Increasing awareness campaigns about sexually transmitted infections and growing emphasis on preventive healthcare measures further stimulate market demand. However, the market faces notable restraints including high costs associated with advanced molecular diagnostic equipment and testing procedures, which limit accessibility in resource-constrained healthcare settings. Additionally, social stigma associated with HSV testing creates psychological barriers that discourage individuals from seeking diagnostic services, potentially limiting market growth. Regulatory complexities and lengthy approval processes for new diagnostic products also pose challenges for market players seeking to introduce innovative solutions. Despite these constraints, significant opportunities emerge from expanding point-of-care testing capabilities, increasing adoption of home-based testing kits that offer privacy and convenience, and growing penetration in emerging markets with improving healthcare infrastructure. The integration of artificial intelligence and machine learning in diagnostic platforms presents opportunities for enhanced accuracy and automated result interpretation, while partnerships between diagnostic companies and telemedicine platforms create new distribution channels and improve testing accessibility in underserved populations.

Key features of the study

• This report provides an in-depth analysis of the global HSV Testing market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global HSV testing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, BioMerieux, Thermo Fisher Scientific, Hologic Inc., BD (Becton Dickinson), Cepheid, Quidel Corporation, DiaSorin, PerkinElmer, Beckman Coulter, Agilent Technologies, Sysmex Corporation, and Ortho Clinical Diagnostics.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global HSV testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global HSV testing market.

Market Segmentation

• HSV Type Insights (Revenue, USD Mn, 2020 - 2032)
  • HSV-2 Testing
  • HSV-1 Testing
  • HSV Type-Unspecified/Combined Tests
• Type Insights (Revenue, USD Mn, 2020 - 2032)
  • Direct Detection or Culture Test (Viral Culture)
  • Molecular Test (PCR Tests, TMA Tests, NAATs etc.)
  • Serological Tests (Antibody Detection etc.)
  • Rapid Antigen Tests (Immunochromatographic)
  • Others (Prenatal Screening Panels and Home Collection Kits, etc.)
• Sample Type Insights (Revenue, USD Mn, 2020 - 2032)
  • Blood/Serum/Plasma
  • Vesicular Swab/Fluid
  • Ulcer/Crust Swab
  • Cerebrospinal Fluid (CSF)
  • Other Body Fluids (e.g., Bronchoalveolar Lavage)
• Age Group Insights (Revenue, USD Mn, 2020 - 2032)
  • Infants and Neonates
  • Children
  • Adults
  • Elderly
• Application Insights (Revenue, USD Mn, 2020 - 2032)
  • Clinical Disease Diagnosis
  • Epidemiological Studies (Screening)
  • Surveillance and Monitoring
  • Others
• End User Insights (Revenue, USD Mn, 2020 - 2032)
  • Hospitals
  • Clinical Diagnostic Laboratories
  • Home Care Settings
  • Point-of-care Settings
  • Blood Banks and Plasma Collection Centers
  • Others (Research and Academic Institutes)
• Regional Insights (Revenue, USD Mn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Roche Diagnostics
  • Abbott Laboratories
  • Siemens Healthineers
  • BioMerieux
  • Thermo Fisher Scientific
  • Hologic Inc.
  • BD (Becton Dickinson)
  • Cepheid
  • Quidel Corporation
  • DiaSorin
  • PerkinElmer
  • Beckman Coulter
  • Agilent Technologies
  • Sysmex Corporation
  • Ortho Clinical Diagnostics

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global HSV Testing Market, By HSV Type
  • Global HSV Testing Market, By Type
  • Global HSV Testing Market, By Sample Type
  • Global HSV Testing Market, By Age Group
  • Global HSV Testing Market, By Application
  • Global HSV Testing Market, By End User
  • Global HSV Testing Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global HSV Testing Market, By HSV Type, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• HSV-2 Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• HSV-1 Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• HSV Type-Unspecified/Combined Tests
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

5. Global HSV Testing Market, By Type, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Direct Detection or Culture Test (Viral Culture)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Molecular Test (PCR Tests, TMA Tests, NAATs etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Serological Tests (Antibody Detection etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Rapid Antigen Tests (Immunochromatographic)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Others (Prenatal Screening Panels and Home Collection Kits, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global HSV Testing Market, By Sample Type, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Blood/Serum/Plasma
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Vesicular Swab/Fluid
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Ulcer/Crust Swab
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Cerebrospinal Fluid (CSF)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Other Body Fluids (e.g., Bronchoalveolar Lavage)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global HSV Testing Market, By Age Group, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Infants and Neonates
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Children
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Adults
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Elderly
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global HSV Testing Market, By Application, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Clinical Disease Diagnosis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Epidemiological Studies (Screening)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Surveillance and Monitoring
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

9. Global HSV Testing Market, By End User, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Clinical Diagnostic Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Home Care Settings
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Point-of-care Settings
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Blood Banks and Plasma Collection Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Others (Research and Academic Institutes)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

10. Global HSV Testing Market, By Region, 2020 - 2032, Value (USD Mn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By HSV Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By HSV Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By HSV Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By HSV Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By HSV Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By HSV Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
    • South Africa
    • North Africa
    • Central Africa

11. Competitive Landscape

• Roche Diagnostics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Abbott Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Siemens Healthineers
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• BioMerieux
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Thermo Fisher Scientific
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Hologic Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• BD (Becton Dickinson)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Cepheid
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Quidel Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• DiaSorin
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• PerkinElmer
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Beckman Coulter
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Agilent Technologies
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sysmex Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Ortho Clinical Diagnostics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

12. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

13. References and Research Methodology

• References
• Research Methodology
• About us